People · Operator
Named in public records as an officer, director or promoter · active 2009–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ImmunityBio, Inc. | — | Biotechnology | Growth/Late | $640.1M | $7.8B | 2015 |
| Biovie Inc. | — | Biotechnology | Series A | $10.5M | $81.1M | 2022 |
| Mimedx Group, Inc. | — | Biotechnology | Seed | $8.2M | $177.6M | 2009 |
Steve J. Gorlin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Steve J. Gorlin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick Soon-Shiong | 1 | 16 |
| Steve Gorlin | 1 | 11 |
| John Brennan | 1 | 9 |
| Richard J. Berman | 1 | 8 |
| Jonathan Adams | 1 | 7 |
| Wesley Clark | 1 | 7 |
| David Sachs | 1 | 5 |
| Parker H. Petit | 1 | 5 |
| John C. Thomas, Jr. | 1 | 5 |
| Mina Sooch | 1 | 5 |
| MICHAEL SHERMAN | 1 | 5 |
| Terren Peizer | 1 | 4 |
| Terren S. Peizer | 1 | 4 |
| Cuong Do | 1 | 4 |
| MATTHEW J. MILLER | 1 | 4 |
| Hari Kumar | 1 | 3 |
| Julie Anderson | 1 | 3 |
| Charles E. Koob | 1 | 3 |
| Barry Simon | 1 | 3 |
| Cheryl Cohen | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.